135 related articles for article (PubMed ID: 15500038)
1. [Antiischemic and antiarrhythmic effect of esafosfina].
Tsorin IB; Chichkanov GG
Eksp Klin Farmakol; 2004; 67(4):16-8. PubMed ID: 15500038
[TBL] [Abstract][Full Text] [Related]
2. [Cardioprotective, inotropic, and anti-arrhythmia properties of a complex adaptogen "Tonizid"].
Lishmanov IuB; Maslov LN; Arbuzov AG; Krylatov AV; Platonov AA; Burkova VN; Kaiumova EA
Eksp Klin Farmakol; 2008; 71(3):15-22. PubMed ID: 18652250
[TBL] [Abstract][Full Text] [Related]
3. The cardioprotective effect of isosteviol on rats with heart ischemia-reperfusion injury.
Xu D; Li Y; Wang J; Davey AK; Zhang S; Evans AM
Life Sci; 2007 Jan; 80(4):269-74. PubMed ID: 17055001
[TBL] [Abstract][Full Text] [Related]
4. [The effect of fructose-1,6-diphosphate and phosphoenolpyruvate on the course of early occlusion and reperfusion arrhythmias in rats].
Balashov VP; Kostin IaV; Sedova DG; Sernov LN; Gatsura VV
Biull Eksp Biol Med; 1993 Jun; 115(6):629-30. PubMed ID: 8374147
[TBL] [Abstract][Full Text] [Related]
5. [Specific bradycardic drug zatebradin: cardiac rhythm variability, antifibrillatory, and antiischemic effects].
Tsorin IB; Palka IP; Kirsanova GIu; Chichkanov GG
Eksp Klin Farmakol; 2008; 71(1):31-5. PubMed ID: 18365484
[TBL] [Abstract][Full Text] [Related]
6. Antiarrhythmic effect of caffeic acid phenethyl ester (CAPE) on myocardial ischemia/reperfusion injury in rats.
Huang SS; Liu SM; Lin SM; Liao PH; Lin RH; Chen YC; Chih CL; Tsai SK
Clin Biochem; 2005 Oct; 38(10):943-7. PubMed ID: 16098504
[TBL] [Abstract][Full Text] [Related]
7. [Cardioprotective and antiarrhythmic properties of Rhodiolae roseae preparations].
Maslov LN; Lishmanov IuB
Eksp Klin Farmakol; 2007; 70(5):59-67. PubMed ID: 18074810
[TBL] [Abstract][Full Text] [Related]
8. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
Lee SH; Yang MK; Lim JH; Seo HW; Yi KY; Yoo SE; Lee BH; Won HS; Lee CS; Choi WS; Shin HS
Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic effect of p-tyrosol on myocardial electric instability induced by coronary occlusion].
Chernyshov GA; Plotnikov MB; Smol'iakova VI; Krasnov EA
Eksp Klin Farmakol; 2007; 70(4):23-5. PubMed ID: 18078037
[TBL] [Abstract][Full Text] [Related]
10. [Effect of the sympathetic nervous system activation on the antifibrillatory efficacy of various anti-arrhythmia agents].
Kaverina NV; Chichkanov GG; Tsorin IB; Kirsanova GIu
Eksp Klin Farmakol; 2000; 63(6):22-3. PubMed ID: 11202504
[TBL] [Abstract][Full Text] [Related]
11. [Antifibrillatory activity of anti-arrhythmia agents in maximally high ligation of the coronary artery and its reperfusion in cats].
Storozhuk BG
Farmakol Toksikol; 1985; 48(3):47-9. PubMed ID: 4029380
[TBL] [Abstract][Full Text] [Related]
12. [Activation of the sympathetic nervous system influences the antifibrillatory effect of class I antiarrhythmic drugs].
Kaverina NV; Chichkanov GG; Tsorin IB; Kirsanova GIu
Eksp Klin Farmakol; 2004; 67(5):17-8. PubMed ID: 15559629
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotection by epsilon-protein kinase C activation from ischemia: continuous delivery and antiarrhythmic effect of an epsilon-protein kinase C-activating peptide.
Inagaki K; Begley R; Ikeno F; Mochly-Rosen D
Circulation; 2005 Jan; 111(1):44-50. PubMed ID: 15611364
[TBL] [Abstract][Full Text] [Related]
14. [Antifibrillatory effect of antiarrhythmic drugs of various classes under conditions of activation of the parasympathetic nervous system].
Kaverina NV; Chichkanov GG; Tsorin IB
Eksp Klin Farmakol; 2004; 67(6):30-1. PubMed ID: 15707011
[TBL] [Abstract][Full Text] [Related]
15. [Comparative study of different classes of anti-arrhythmia agents on the vulnerability of ischemic ventricular fibrillation].
Aupetit JF; Timour Q; Chevrel G; Omar S; Loufoua-Moundanga J; Faucon G
Therapie; 1993; 48(4):403-7. PubMed ID: 8128424
[TBL] [Abstract][Full Text] [Related]
16. [Comparative characteristics of the experimental antifibrillatory action of anti-arrhythmia preparations].
Storozhuk BG; Stoliarchuk AA
Farmakol Toksikol; 1980; 43(5):579-81. PubMed ID: 7449988
[TBL] [Abstract][Full Text] [Related]
17. Gamma-irradiated ceruloplasmin affords antifibrillatory protection against ischemia/reperfusion damage in the isolated rat heart.
Assemand E; Lacroix M; Chahine R; Nadeau R; Mateescu MA
Int J Radiat Biol; 2007 May; 83(5):309-17. PubMed ID: 17457756
[TBL] [Abstract][Full Text] [Related]
18. [Comparative study of the antiarrhythmic activity of mu- and delta-opioid receptor agonists during acute cardiac ischemia and reperfusion models in rats].
Solenkova NV; Maslov LN; Budankova EV; Lishmanov AIu; Oeltgen P; Govindaswami M; Bespalova ZhD; Ovchinnikov MV; Nagaze H
Eksp Klin Farmakol; 2005; 68(6):25-9. PubMed ID: 16405030
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of carbon monoxide-releasing molecules on post-ischemic myocardial recovery.
Varadi J; Lekli I; Juhasz B; Bacskay I; Szabo G; Gesztelyi R; Szendrei L; Varga E; Bak I; Foresti R; Motterlini R; Tosaki A
Life Sci; 2007 Apr; 80(17):1619-26. PubMed ID: 17321552
[TBL] [Abstract][Full Text] [Related]
20. [Anti-arrhythmic properties of specific bradycardic agents from the group of 2-mercaptobenzimidazole derivatives].
Chichkanov GG; Tsorin IB; Kirsanova GIu; Berdiaev SIu; Turilova AI
Eksp Klin Farmakol; 1997; 60(5):35-9. PubMed ID: 9483403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
